Grifols SA (GRFS)
9.205
-0.02
(-0.16%)
USD |
NASDAQ |
Feb 11, 16:00
9.205
0.00 (0.00%)
After-Hours: 16:16
Grifols Total Assets (Quarterly) : 23.33B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Akari Therapeutics Plc | 45.38M |
| Pharma Mar SA | 401.45M |
| Autolus Therapeutics Plc | 661.95M |
| Oryzon Genomics SA | 171.17M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.46B |
| Shareholders Equity (Quarterly) | 6.085B |
| Debt to Equity Ratio | 1.871 |
| Current Ratio | 2.482 |
| Net Debt Paydown Yield | 0.06% |